SU586642A1 - Derivatives of imidazolidingo-(3,2-f)-pyrido-(2,3-b)- or imidazolidingo-(3,2-f)-pyrimido-(4,5-b)-(1,4)-thiazines and process for producing the same - Google Patents
Derivatives of imidazolidingo-(3,2-f)-pyrido-(2,3-b)- or imidazolidingo-(3,2-f)-pyrimido-(4,5-b)-(1,4)-thiazines and process for producing the same Download PDFInfo
- Publication number
- SU586642A1 SU586642A1 SU762345074A SU2345074A SU586642A1 SU 586642 A1 SU586642 A1 SU 586642A1 SU 762345074 A SU762345074 A SU 762345074A SU 2345074 A SU2345074 A SU 2345074A SU 586642 A1 SU586642 A1 SU 586642A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- ppm
- pyrido
- dioxo
- thiazine
- spectrum
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- ZAISDHPZTZIFQF-UHFFFAOYSA-N 2h-1,4-thiazine Chemical compound C1SC=CN=C1 ZAISDHPZTZIFQF-UHFFFAOYSA-N 0.000 claims description 8
- 238000002329 infrared spectrum Methods 0.000 claims description 6
- 238000001228 spectrum Methods 0.000 claims description 6
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims description 4
- 239000005695 Ammonium acetate Substances 0.000 claims description 4
- 229960000583 acetic acid Drugs 0.000 claims description 4
- 229940043376 ammonium acetate Drugs 0.000 claims description 4
- 235000019257 ammonium acetate Nutrition 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 239000012362 glacial acetic acid Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 3
- UDJFFSGCRRMVFH-UHFFFAOYSA-N pyrido[2,3-d]pyrimidine Chemical compound N1=CN=CC2=CC=CN=C21 UDJFFSGCRRMVFH-UHFFFAOYSA-N 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 239000000460 chlorine Chemical group 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 239000013078 crystal Substances 0.000 claims 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- 150000001408 amides Chemical class 0.000 claims 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 4
- BOEFGXVQFYTJAG-UHFFFAOYSA-N 3h-pyrido[2,3-b][1,4]thiazine Chemical compound C1=CC=C2N=CCSC2=N1 BOEFGXVQFYTJAG-UHFFFAOYSA-N 0.000 claims 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 2
- 239000002244 precipitate Substances 0.000 claims 2
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 claims 1
- 101150065749 Churc1 gene Proteins 0.000 claims 1
- 102100038239 Protein Churchill Human genes 0.000 claims 1
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- 150000001793 charged compounds Chemical class 0.000 description 3
- 125000000623 heterocyclic group Chemical group 0.000 description 3
- NTYABNDBNKVWOO-UHFFFAOYSA-N 2h-1,3-thiazine Chemical class C1SC=CC=N1 NTYABNDBNKVWOO-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- WQEBRZKYXXZALY-UHFFFAOYSA-N 2h-pyrido[2,3-e]thiazine Chemical group C1=CN=C2C=CNSC2=C1 WQEBRZKYXXZALY-UHFFFAOYSA-N 0.000 description 1
- LATZNTJAPMNLAZ-UHFFFAOYSA-N 2h-pyrimido[4,5-e]thiazine Chemical compound N1=CN=C2C=CNSC2=C1 LATZNTJAPMNLAZ-UHFFFAOYSA-N 0.000 description 1
- AGIJRRREJXSQJR-UHFFFAOYSA-N 2h-thiazine Chemical group N1SC=CC=C1 AGIJRRREJXSQJR-UHFFFAOYSA-N 0.000 description 1
- YOQIAZANPNMQAT-UHFFFAOYSA-N 7h-pyrimido[4,5-b][1,4]thiazine Chemical class C1=NC=C2N=CCSC2=N1 YOQIAZANPNMQAT-UHFFFAOYSA-N 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Landscapes
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Изобретение относитс к способу получени новой гетероциклической системы - имидазолидино(3,2-1) пиридо (2, З-Ь)- или имидазолидино- (3,4 ) пиримидо (4,5-Ь) (1,4)тиазинов ..The invention relates to a method for producing a new heterocyclic system - imidazolidino (3.2-1) pyrido (2, 3-b) - or imidazolidino- (3,4) pyrimido (4,5-b) (1,4) thiazines.
Известныразличные гетероциклические системы, включающие конденсированные пиридиновые или пиримидиновые и тиазиновые циклы, обладающие широким спектром биологического действи . Ближайшими 4 аналогами целевых соединений вл ютс оксазолидино (3,2-)пиридо(2,3-Ь)и оксазолидино (3,2-4) пиримидо (4,5-13) (1, 4)тиазины , содержащие пиридо- или пиримидотиазинсвую систему, сконденсированную с оксазольным циклом 5, а также пиридо(3,2-4,5)имидазоло(2,1-Ъ ( 1,3)тиазины, содержащие пиридоимидазольную систему, сконденсированную с 1,3-тиазиновым циклом, которые также вл ютс биологическ 1 активными соединени ми бVarious heterocyclic systems are known, including condensed pyridine or pyrimidine and thiazine rings, which have a wide spectrum of biological effects. The closest 4 analogues of the target compounds are oxazolidino (3,2-) pyrido (2,3-b) and oxazolidino (3,2-4) pyrimido (4,5-13) (1, 4) thiazines containing pyrido or pyrimidothiazine system condensed with oxazole cycle 5, as well as pyrido (3,2-4,5) imidazolo (2,1-b (1,3) thiazines containing a pyri-imidazole system condensed with a 1,3-thiazine cycle, which also are biological 1 active compounds b
Цаль изобретени - синтез новых гетероциклических систем, в которых пиридо- или пиримидотиаэнновые системы сконденсированы с имидазольым циклом, общей формулыThe invention is based on the synthesis of new heterocyclic systems in which pyrido- or pyrimidothiaanne systems are condensed with an imidazole ring, of the general formula
,,
(I)(I)
xXJ,xXJ,
3 5 .3 5.
где R - водород, хлорwhere R is hydrogen, chlorine
R. - водород, матоксигруппа; R метил,этил, пропил, бутил; X - N или СН,R. - hydrogen, matoxy; R methyl, ethyl, propyl, butyl; X - N or CH,
обладающих биологической активностью, Способ получени предложенных соединений заключаетс в том, что соединени общей формулыpossessing biological activity; A method for producing the proposed compounds is that the compounds of the general formula
о гс--с оabout gf - with about
1 /one /
A-VAv
OCDOCD
хx
-S( -S (
R.R.
К„ и X имеют указанныеTo „and X have indicated
где R, t , значени ,where R, t, meaning
подвергают взаимодействию с ацетатом аммони в органической кислоте при нагревании.reacted with ammonium acetate in organic acid when heated.
В качестве органических кислот используют лед ную уксусную кислоту и процесс провод т при вО-ЮО С.As organic acids, glacial acetic acid is used and the process is carried out at HE-SOO C.
Выход целевых продуктов составл ет 80-90%.The yield of the target products is 80-90%.
Строение имидазолидино (3,2-|)пиридо (2,3-1)- и имидаэолидино(3, 2-.f) пиримидо(4,S-fe)(1,4)тиазинов подтверждено с помощью ИК-, IIMP- и массСП ектрометрии.The structure of imidazolidino (3,2- |) pyrido (2,3-1) - and imidaeolidino (3, 2-.f) pyrimido (4, S-fe) (1,4) thiazines was confirmed by IR, IIMP- and mass spectrometry.
В ИК-спектре имеютс полосы поглощени группы.NH в области (3030 3290 см-) и групп СО (1730-1780 см ), В спектрах ПМР сигнал протонов группы СН представлен в виде двух дуолетов с константой геминального взаимодействи Э 12 Гц,In the IR spectrum there are absorption bands of the group. NH in the region (3030 3290 cm-) and CO groups (1730-1780 cm). In the PMR spectra, the signal of the protons of the CH group is represented as two duolets with a constant of geminal interaction E 12 Hz,
В масс-спектре имидазолидино(3,2-{ ) пиримидо (4,) (1,4)-тиаэина наблюдаетс пик молекул рного иона с массовым числом 280, а также фрагменты , обусловленные выбросом из молекул рного иона радикала с массовым числом 29. Интенсиновый пик С массовым числом 29 относитс к фрагменту, полученному при отрыве из молекул рного иона СО и CONH-rpynn-71ТЖ: С 5 -kl JIn the mass spectrum of imidazolidino (3,2- {) pyrimido (4,) (1,4) -taaine, a peak of a molecular ion with a mass number of 280 is observed, as well as fragments caused by the release of a radical mass with a mass number of 29 from a molecular ion. Intense peak With a mass number of 29, refers to a fragment obtained by detaching the molecular ion CO and CONH-rpynn-71TJ: C 5 -kl J
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU762345074A SU586642A1 (en) | 1976-04-08 | 1976-04-08 | Derivatives of imidazolidingo-(3,2-f)-pyrido-(2,3-b)- or imidazolidingo-(3,2-f)-pyrimido-(4,5-b)-(1,4)-thiazines and process for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU762345074A SU586642A1 (en) | 1976-04-08 | 1976-04-08 | Derivatives of imidazolidingo-(3,2-f)-pyrido-(2,3-b)- or imidazolidingo-(3,2-f)-pyrimido-(4,5-b)-(1,4)-thiazines and process for producing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
SU586642A1 true SU586642A1 (en) | 1982-10-07 |
Family
ID=20656002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU762345074A SU586642A1 (en) | 1976-04-08 | 1976-04-08 | Derivatives of imidazolidingo-(3,2-f)-pyrido-(2,3-b)- or imidazolidingo-(3,2-f)-pyrimido-(4,5-b)-(1,4)-thiazines and process for producing the same |
Country Status (1)
Country | Link |
---|---|
SU (1) | SU586642A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0795557A1 (en) * | 1996-03-13 | 1997-09-17 | Takeda Chemical Industries, Ltd. | Condensed thiazine derivatives their production and use |
-
1976
- 1976-04-08 SU SU762345074A patent/SU586642A1/en active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0795557A1 (en) * | 1996-03-13 | 1997-09-17 | Takeda Chemical Industries, Ltd. | Condensed thiazine derivatives their production and use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU735170A3 (en) | Method of preparing esters of 7-beta-acylamido-3-methylceph-3-em-4-carboxylic acid | |
SU575031A3 (en) | Method of preparing condensed tricyclic derivatives of imidazole or their salts | |
SU586642A1 (en) | Derivatives of imidazolidingo-(3,2-f)-pyrido-(2,3-b)- or imidazolidingo-(3,2-f)-pyrimido-(4,5-b)-(1,4)-thiazines and process for producing the same | |
ES2718038T3 (en) | Apixaban dimeric impurities and method of eliminating them | |
CN110078664B (en) | Phosgene fluorescent probe and preparation method thereof | |
SU900809A3 (en) | Process for preparing n-cyano-n'- 2-/(4-methyl-5-imidazolyl) methylthio/ethyl n''-alkenylguanidines or their salts | |
IE42115L (en) | Substituted indolenines. | |
Hoagland et al. | The formation of intermediate lactones during aminolysis of diethyl xylarate | |
Hansen et al. | N-nitrosothialdine. Synthesis, X-ray crystallography, and NN rotational barrier | |
Rice et al. | Color Formation in Furfural Systems1 | |
SU679142A3 (en) | Method of producing 2h-pyran-2,6(3h)-dione derivatives or salts thereof | |
CN111196791A (en) | A kind of chiral γ-butyrolactone derivative and its synthesis method and application | |
SU526621A1 (en) | The method of obtaining derivatives of spirochromenes acridine row | |
SU615653A1 (en) | Process for producing 2,3-substituted-4-amino-6,7-dihydro-5h-1-pyridines | |
SU721428A1 (en) | 1,3-bis(2',4'-dioxybutyl)-5-oxymethylisocyanuric acid as adhesion-additive to glue-melts | |
SU414254A1 (en) | ||
SU1395633A1 (en) | Method of producing 2,6-dioxypiperazine | |
SU407911A1 (en) | Method of producing tetraalkyl ethers of isophosphoric acid | |
SU1101442A1 (en) | Process for preparing 10-styrylpyrimido (1,2-a)indol-2-ones | |
SU1198070A1 (en) | Method of producing 10-cyanophenothiazine | |
SU794010A1 (en) | Bicyclic spiral ketolactones as polymer stabilizers | |
SU632695A1 (en) | Method of obtaining 2-oxo-4-phenyl-5-carbethoxy-6-methylpypimidine | |
SU1402601A1 (en) | Method of producing 8-mercapto-1-methyl-2-methylthiohypoxanthine | |
Yamazaki et al. | Synthesis in the diazasteroid group. III. Syntheses of the 8, 16‐and 8, 17‐diazasteroid systems | |
SU891672A1 (en) | Method of preparing derivatives of pyridazino /1,6-a/benzimidazole |